Project Inform

Last updated
Project Inform
Project Inform logo thumbnail, 2010.gif
Formation1984
Headquarters San Francisco, California
Interim Executive Director
David Evans
Website

Project Inform is an American advocacy group dedicated to improving the health of and empowering people with HIV and hepatitis C, involving them in the process of developing therapies for the disease, and ending the AIDS pandemic. The organization deliberately focuses its efforts on issues that few other agencies address. Main areas of focus include drug development, bio-medical prevention, education and health care access.

In the years since its founding the work of Project Inform helped to found the community-based HIV research movement, helped to proliferate HIV treatment education and make it available to patients and care providers, and lead a national movement to accelerate approval by the U. S. Food and Drug Administration of critical drugs and other treatments for AIDS. [1] [2] [3]

PI was founded in 1984 by Martin Delaney and Joe Brewer. [4]

Related Research Articles

Médecins Sans Frontières International humanitarian medical non-governmental organization

Médecins Sans Frontières, sometimes rendered in English as Doctors Without Borders, is an international humanitarian medical non-governmental organisation (NGO) of French origin best known for its projects in conflict zones and in countries affected by endemic diseases. Main areas of work include diabetes, drug-resistant infections, HIV/AIDS, hepatitis C, tropical and neglected diseases, tuberculosis, vaccines and COVID. They contribute to patents and intellectual property subjects, as well as research and development. In 2019, the group was active in 70 countries with over 35,000 personnel mostly local doctors, nurses and other medical professionals, logistical experts, water and sanitation engineers and administrators. Private donors provide about 90% of the organisation's funding, while corporate donations provide the rest, giving MSF an annual budget of approximately US$1.63 billion.

HIV/AIDS in the United States Epidemic in the United States

The AIDS epidemic, caused by HIV, found its way to the United States as early as 1960, but was first noticed after doctors discovered clusters of Kaposi's sarcoma and pneumocystis pneumonia in homosexual men in Los Angeles, New York City, and San Francisco in 1981. Treatment of HIV/AIDS is primarily via the use of multiple antiretroviral drugs, and education programs to help people avoid infection.

HIV/AIDS in India

HIV/AIDS in India is an epidemic. The National AIDS Control Organisation (NACO) estimated that 2.14 million people lived with HIV/AIDS in India in 2017. Despite being home to the world's third-largest population of persons with HIV/AIDS, the AIDS prevalence rate in India is lower than that of many other countries. In 2016, India's AIDS prevalence rate stood at approximately 0.30%—the 80th highest in the world. Treatment of HIV/AIDS is primarily via a "drug cocktail" of antiretroviral drugs and education programs to help people avoid infection.

AIDS service organizations are community-based organizations that provide support for people affected by HIV/AIDS. This article focuses on HIV/AIDS service organizations in the United States only.

The Pontifical Council for the Pastoral Care of Health Care Workers was set up on 11 February 1985 by Pope John Paul II who reformed the Pontifical Commission for the Pastoral Assistance to Health Care Workers into its new form in 1988. It was part of the Roman Curia.

Human immunodeficiency virus and acquired immune deficiency syndrome in Burma is recognised as a disease of concern by the Ministry of Health and is a major social and health issue in the country. In 2005, the estimated adult HIV prevalence rate in Burma was 1.3%, according to UNAIDS, and early indicators show that the epidemic may be waning in the country, although the epidemic continues to expand in parts of the country. Four different strains of HIV are believed to have originated from Burma, along heroin trafficking routes in northern, eastern and western Burma.

According to experts, the total number of individuals with HIV was estimated in 2016 to be between 0.85 and 1.5 million. As for 2016, the prevalence of HIV in adult people was between 0.8 and 1%, and according to the UN, Russia had one of the fastest growing HIV/AIDS epidemics in the world. Approximately 95,000 Russians were diagnosed with HIV in 2015, and approximately 75,000 in the first nine months of 2016. Stigma surrounding the disease, and government indifference have contributed to the crisis. As of 2016 the HIV/AIDS epidemic, despite successes with intravenous drug users, was poised to move into the general population of sexually active young people.

Whitman-Walker Health (WWH), formerly Whitman-Walker Clinic, is a non-profit community health center in the Washington, D.C. metropolitan area with a special expertise in HIV/AIDS healthcare and LGBT healthcare. Founded as an affirming health center for the gay and lesbian community in 1978, Whitman-Walker was one of the first responders to the HIV/AIDS epidemic in D.C. and became a leader in HIV/AIDS education, prevention, diagnosis and treatment. In recent years, Whitman-Walker has expanded its services to include primary healthcare services, a stronger focus on queer women's care and youth services.

With less than 0.1 percent of the population estimated to be HIV-positive, Bangladesh is a low HIV-prevalence country.

According to the Global Fund, Honduras is the Central American country most adversely affected by the HIV/AIDS epidemic. As of 1998, Honduras had the highest prevalence of HIV out of all seven Central American countries according to a study published by the office of the Honduran Secretary of Public Health. As of that same year, Hondurans made up only 17% of the Central American population, yet Honduras contained 50% of the initial AIDS cases in Central America and 60% of all Central American cases in 2001. In more recent years, new HIV infections have decreased by 29% since 2010 while AIDS-related deaths have increased by 11% since then. HIV/AIDS heavily affects the young, active, working population in Honduras, and HIV/AIDS deaths account for 10% of the overall national mortality rate. As of 2008, AIDS was the leading cause of death among Honduran women of childbearing age and the second-leading cause of hospitalization among both men and women. Sexually transmitted infections are common, and condom use in risky sexual encounters is sporadic and variable. HIV remains a mainly heterosexual epidemic in Honduras, as 90% of emerging infections are attributed to heterosexual transmission. It is estimated that the prevalence of HIV among Honduran adults is 1.5%.

With less than 1 percent of the population estimated to be HIV-positive, Egypt is a low-HIV-prevalence country. However, between the years 2006 and 2011, HIV prevalence rates in Egypt increased tenfold. Until 2011, the average number of new cases of HIV in Egypt was 400 per year. But, in 2012 and 2013 it increased to about 600 new cases and in 2014 it reached 880 new cases per year. According to UNAIDS 2016 statistics, there are about 11,000 people currently living with HIV in Egypt. The Ministry of Health and Population reported in 2020 over 13000 Egyptians are living with HIV/AIDS. However, unsafe behaviors among most-at-risk populations and limited condom usage among the general population place Egypt at risk of a broader epidemic.

Avert (HIV and AIDS organisation) British charitable organization

Avert is an international HIV and AIDS charity based in Brighton, United Kingdom. The charity provides information and education on HIV and AIDS. It partners with organizations in countries most affected by HIV.

HIV/AIDS in Canada

HIV/AIDS was first detected in Canada in 1982. In 2018, there were approximately 62,050 people living with HIV/AIDS in Canada. It was estimated that 8,300 people were living with undiagnosed HIV in 2018. Mortality has decreased due to medical advances against HIV/AIDS, especially highly active antiretroviral therapy (HAART).

Martin "Marty" Delaney was an advocate for HIV/AIDS treatments. In 1985, he founded Project Inform, an education and public policy advocacy group concerned with HIV and AIDS, and continued to lead the organization until 2008. Delaney's efforts to streamline the US Food and Drug Administration's drug approval process have been credited with saving thousands of people from early AIDS deaths.

The Catholic Church is a major provider of medical care to HIV/AIDS patients. Much of its work takes place in developing countries, although it has also had a presence in the global north. Its opposition to condoms, despite their effectiveness in preventing the spread of HIV, has invited criticism from public health officials and anti-AIDS activists.

The relationship between religion and HIV/AIDS has been an ongoing one, since the advent of the pandemic. Many faith communities have participated in raising awareness about HIV/AIDS, offering free treatment, as well as promoting HIV/AIDS testing and preventative measures. Christian denominations, such as Lutheranism and Methodism, have advocated for the observance of World AIDS Day to educate their congregations about the disease. Some Churches run voluntary blood testing camps and counselling centers to diagnose and help those affected by HIV/AIDS.

Eric Goosby American public health official

Eric Goosby is an American public health official, currently serving as the UN Special Envoy on Tuberculosis. Goosby previously served as the United States Global AIDS Coordinator from 2009 until mid-November 2013. In the role, Goosby directed the U.S. strategy for addressing HIV around the world and led President Obama's implementation of the President's Emergency Plan for AIDS Relief (PEPFAR). Goosby was sworn in during June 2009 and resigned in November 2013, taking a position as a professor at UCSF, where he directs the Center for Global Health Delivery and Diplomacy, a collaboration between UCSF and the University of California, Berkeley.

Discrimination against people with HIV/AIDS or serophobia is the prejudice, fear, rejection, and stigmatization of people afflicted with HIV/AIDS. Marginalized, at-risk groups such as members of the LGBTQ+ community, intravenous drug users, and sex workers are most vulnerable to facing HIV/AIDS discrimination. The consequences of societal stigma against PLHIV are quite severe, as HIV/AIDS discrimination actively hinders access to HIV/AIDS screening and care around the world. Moreover, these negative stigmas become used against members of the LGBTQ+ community in the form of stereotypes held by physicians.

Julio S. G. Montaner, is an Argentine-Canadian physician, professor and researcher. He is the director of the British Columbia Centre for Excellence in HIV/AIDS, the chair in AIDS Research and head of the Division of AIDS in the Faculty of Medicine at the University of British Columbia and the past-president of the International AIDS Society. He is also the director of the John Ruedy Immunodeficiency Clinic, and the Physician Program Director for HIV/AIDS PHC. He is known for his work on HAART, a role in the discovery of triple therapy as an effective treatment for HIV in the late 1990s, and a role in advocating the "Treatment as Prevention" Strategy in the mid-2000s, led by Myron Cohen of the HPTN 052 trial.

HIV/AIDS activism Social movement advocating for a societal response to HIV/AIDS

Social activism against the spread of HIV/AIDS and in support of effective treatment has taken place in multiple nations across the world over the past several decades. In terms of the complex history of HIV/AIDS in human beings, widespread criticism by regular individuals against public health organizations have escalated into protest movements due to slow treatment responses. Methods of demonstration have included pamphleteer activities, placard waving, public marches, sit-ins, the hanging of political leaders in effigy, and the like.

References

  1. Sawyer, Eric (January 27, 2009). "In Memory of Martin Delaney: The Founder of Project Inform". UNAIDS . Retrieved July 17, 2010.
  2. Roehr, Bob (January 27, 2009). "Tribute: HIV Treatment Activist Martin Delaney". Medscape . Retrieved July 17, 2010.
  3. Whiting, Sam (January 25, 2009), "Martin Delaney, HIV patient advocate, dies", San Francisco Chronicle
  4. Kahn, Arthur D. (2005), AIDS, the Winter War: A Testing of America, Bloomington, Indiana: iUniverse, p. 14, ISBN   978-0-595-36637-8